UnknownNCT05628558
Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A
Studying Mild hemophilia A
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Groupe Maladies hémorragiques de Bretagne
- Principal Investigator
- Benoît Guillet, MDCHU Rennes
- Intervention
- Desmopressin(drug)
- Enrollment
- 800 enrolled
- Eligibility
- 2-80 years · MALE
- Timeline
- 2020 – 2023
Study locations (1)
- University hospital of Rennes, Rennes, Brittany Region, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05628558 on ClinicalTrials.gov